Skip to main content
logo
Nika Pharmaceuticals, Inc. (NIKA)
OTCMKTS · Delayed Price · Currency is USD
0.41999
-0.09001 (-17.65%)
At close: Aug 12, 2026

Nika Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
442395517---
Market Cap Growth
-54.59%-23.51%----
Enterprise Value
442395517---
Last Close Price
0.420.380.51---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
-1335.72-1327.72-2335.19---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.03-1.07-1.08-1.24-1.05-
Net Debt / Equity Ratio
-1.02-1.06-1.07-1.00-1.000.02
Quick Ratio
0.010.010.010.190.050.04
Current Ratio
0.030.070.080.190.050.04
Return on Assets (ROA)
-235.04%-245.31%-319.05%-396.10%-315344.21%-914.93%
Return on Capital Employed (ROCE)
23.60%25.70%43.30%78.90%18386.00%145.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.02%-0.02%-0.02%---
Buyback Yield / Dilution
-3.37%-2.53%-16.62%-21.02%-82.78%-